Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - GB
$ 9.39
0.859 %
$ 42.5 B
Market Cap
27.62
P/E
BALANCE SHEET
34.1 B
ASSETS
17.3 B
LIABILITIES
16.6 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Haleon plc
| Current Assets | 4.82 B |
| Cash & Short-Term Investments | 1.04 B |
| Receivables | 1.35 B |
| Other Current Assets | 2.42 B |
| Non-Current Assets | 29.2 B |
| Long-Term Investments | 65 M |
| PP&E | 1.9 B |
| Other Non-Current Assets | 27.3 B |
| Current Liabilities | 4.64 B |
| Accounts Payable | 1.86 B |
| Short-Term Debt | 656 M |
| Other Current Liabilities | 2.13 B |
| Non-Current Liabilities | 12.7 B |
| Long-Term Debt | 8.95 B |
| Other Non-Current Liabilities | 3.74 B |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 1 044.0 | 684.0 | 414.0 | 334.0 | 340.0 |
| Short Term Investments | 0 | 0 | 1.0 | 1.0 | 1.0 |
| Receivables | 1 352.0 | 1 487.0 | 3 825.0 | 3 590.0 | 3 994.0 |
| Inventory | 1 408.0 | 1 348.0 | 951.0 | 949.0 | 1 211.0 |
| Other Current Assets | 1 014.0 | 540.0 | 2 568.0 | 2 377.0 | 2 863.0 |
| Total Current Assets | 4 818.0 | 4 059.0 | 5 251.0 | 5 008.0 | 5 811.0 |
| PP&E | 1 902.0 | 1 899.0 | 1 662.0 | 1 602.0 | 1 621.0 |
| Intangible Assets | 18 538.0 | 20 040.0 | 18 949.0 | 18 953.0 | 19 841.0 |
| Goodwill | 8 317.0 | 8 396.0 | 8 246.0 | 8 265.0 | 8 171.0 |
| Long Term Investments | 65.0 | 44.0 | 23.0 | 41.0 | 3.0 |
| Other Long Term Assets | 415.0 | 157.0 | 8.0 | 10.0 | 10.0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 34 055.0 | 34 815.0 | 34 451.0 | 34 130.0 | 35 711.0 |
| LIABILITIES | |||||
| Accounts Payable | 1 855.0 | 1 835.0 | 1 579.0 | 1 827.0 | 1 898.0 |
| Short Term Debt | 656.0 | 437.0 | 922.0 | 382.0 | 521.0 |
| Other Current Liabilities | 1 841.0 | 1 888.0 | 1 500.0 | 1 527.0 | 1 624.0 |
| Total Current Liabilities | 4 640.0 | 4 370.0 | 4 238.0 | 4 014.0 | 4 269.0 |
| Long Term Debt | 8 950.0 | 10 178.0 | 88.0 | 105.0 | 121.0 |
| Deferred Tax Income | 0 | 3 601.0 | 3 357.0 | 3 373.0 | 3 514.0 |
| Other Liabilities | 3 736.0 | 3 810.0 | 3 364.0 | 3 387.0 | 3 535.0 |
| Total Liabilities | 17 326.0 | 18 358.0 | 7 971.0 | 7 907.0 | 8 299.0 |
| EQUITY | |||||
| Common Stock | 92.0 | 92.0 | 1.0 | 1.0 | 1.0 |
| Retained Earnings | 27 474.0 | 26 730.0 | 37 986.0 | 37 763.0 | 5 106.0 |
| Other Accumulative Comprehensive Income/Loss | 765.0 | 1 196.0 | (11 632.0) | (11 652.0) | 1 372.0 |
| Total Equity | 16 729.0 | 16 457.0 | 26 480.0 | 26 223.0 | 27 412.0 |
| Total Liabilities and Equity | 34 055.0 | 34 815.0 | 34 451.0 | 34 130.0 | 35 711.0 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 9 263.0 | 9 235.0 | 9 234.6 | 9 234.6 | 9 234.6 |